---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-014816"
form_type: "8-K"
ticker: null
cik: "0000849636"
company_name: "RespireRx Pharmaceuticals Inc."
filed_at: "2024-04-16T23:59:59+00:00"
generated_at: "2026-06-03T22:39:17.332955+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# RespireRx enters $100K demand note with director Nasiek; warrant for 33.3M shares

## Summary
- $100,000 demand promissory note issued to Dariusz Nasiek and Sara Nasiek JTTEN; 10% interest payable on demand.
- Warrant to purchase 33,333,333 shares of common stock at $0.0015/share, exercisable for 5 years.
- Proceeds used for working capital, R&D, and general corporate purposes.
- Dariusz Nasiek is a Board member; transaction is a related-party arrangement.

## SEC filing metadata
- accession: 0001493152-24-014816
- form_type: 8-K
- cik: 0000849636
- company_name: RespireRx Pharmaceuticals Inc.
- filed_at: 2024-04-16T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/849636/000149315224014816/0001493152-24-014816-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/849636/000149315224014816/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-014816
- JSON: https://secwatch.observer/filing/0001493152-24-014816.json
- Plain text: https://secwatch.observer/filing/0001493152-24-014816.txt

## Key facts
- Material Agreements
  RespireRx Pharmaceuticals Inc. entered into Purchase Agreement with Dariusz Nasiek and Sara Nasiek, JTTEN valued at $100,000.00 (effective 2024-04-10).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: Dariusz Nasiek and Sara Nasiek, JTTEN
  - Value: $100,000.00
  - Effective: 2024-04-10
  source text: On April 10, 2024, the RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”) entered into a Demand Promissory Note and Warrant Agreement (“Purchase Agreement”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/849636/000149315224014816/0001493152-24-014816-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.